{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:05:17Z","timestamp":1790024717633,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lanepe.2021.100253","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T19:07:51Z","timestamp":1635448071000},"page":"100253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-032X","authenticated-orcid":false,"given":"Martina","family":"Amanzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos D","family":"Mitsikostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-9293","authenticated-orcid":false,"given":"Giuseppina Elena","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2021.100253_bib0001","first-page":"203","article-title":"The nocebo reaction","volume":"95","author":"Kennedy","year":"1961","journal-title":"Med World"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100253_bib0002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41584-018-0110-9","article-title":"Nocebos in rheumatology: emerging concepts and their implications for clinical practice","volume":"14","author":"Kravvariti","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100253_bib0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pec.2011.04.034","article-title":"The placebo response: how words and rituals change the patient's brain","volume":"84","author":"Benedetti","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"10188","key":"10.1016\/j.lanepe.2021.100253_bib0004","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0140-6736(19)30419-2","volume":"393","author":"Smolen","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100253_bib0005","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/rheumatology\/keaa576","article-title":"Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study","volume":"60","author":"Smolen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100253_bib0006","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.40324","article-title":"Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab","volume":"70","author":"Tweehuysen","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100253_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pain.2009.07.010","article-title":"A systematic review of adverse events in placebo groups of anti-migraine clinical trials","volume":"146","author":"Amanzio","year":"2009","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100253_bib0008","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2165\/11316580-000000000-00000","article-title":"Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis","volume":"32","author":"Rief","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.lanepe.2021.100253_bib0009","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2388","article-title":"Hypothalamic-Pituitary-Adrenal Activity in Adverse Events Reporting after Placebo Administration","author":"Benedetti","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"37","key":"10.1016\/j.lanepe.2021.100253_bib0010","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1016\/j.vaccine.2011.05.045","article-title":"Disease-specific adverse events following nonlive vaccines: a paradoxical placebo effect or a nocebo phenomenon?","volume":"29","author":"Oka\u00efs","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lanepe.2021.100253_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2021.100253_bib0012","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"187","article-title":"Chapter 8: Assessing Risk of Bias in Included Studies","author":"Higgins","year":"2008"},{"key":"10.1016\/j.lanepe.2021.100253_bib0013","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"27","key":"10.1016\/j.lanepe.2021.100253_bib0014","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100253_bib0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.lanepe.2021.100253_bib0016","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanepe.2021.100253_bib0017","series-title":"Knowledge, concepts, and categories","first-page":"43","article-title":"Concepts and similarity","author":"Hahn","year":"1997"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100253_bib0018","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1037\/0021-9010.80.5.628","article-title":"Seasickness as a self-fulfilling prophecy: raising self-efficacy to boost performance at sea","volume":"80","author":"Eden","year":"1995","journal-title":"J Appl Psychol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100253_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2007.05.008","article-title":"Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study","volume":"35","author":"Shelke","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100253_bib0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1037\/0003-066X.40.11.1189","article-title":"Response expectancy as a determinant of experience and behavior","volume":"40","author":"Kirsch","year":"1985","journal-title":"American Psychologist"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100253_bib0021","first-page":"451","article-title":"The nocebo effect: a reason for patients' non-adherence to generic substitution?","volume":"65","author":"Weissenfeld","year":"2010","journal-title":"Pharmazie"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100253_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PSY.0b013e3182738826","article-title":"The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects","volume":"75","author":"Faasse","year":"2013","journal-title":"Psychosom Med"},{"key":"10.1016\/j.lanepe.2021.100253_bib0023","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00006842-199903000-00018","article-title":"Drug-related information generates placebo and nocebo responses that modify the drug response","volume":"61","author":"Flaten","year":"1999","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100253_bib0024","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00006842-197009000-00009","article-title":"The interaction of psychologic stimuli and pharmacologic agents on airway reactivity in asthmatic subjects","volume":"32","author":"Luparello","year":"1970","journal-title":"Psychosom Med"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100253_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006842-196903000-00007","article-title":"The mechanism of action of suggestion in the induction of acute asthma attacks","volume":"31","author":"McFadden","year":"1969","journal-title":"Psychosom Med"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100253_bib0026","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00006842-196811000-00002","article-title":"Influences of suggestion on airway reactivity in asthmatic subjects","volume":"30","author":"Luparello","year":"1968","journal-title":"Psychosom Med"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100253_bib0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM199008163230701","article-title":"A double-blind study of symptom provocation to determine food sensitivity","volume":"323","author":"Jewett","year":"1990","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100253_bib0028","first-page":"104","article-title":"Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions","volume":"14","author":"Liccardi","year":"2004","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100253_bib0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/clpt.1987.142","article-title":"The consent form as a possible cause of side effects","volume":"42","author":"Myers","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanepe.2021.100253_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.589884","article-title":"How Do Nocebo Phenomena Provide a Theoretical Framework for the COVID-19 Pandemic?","volume":"11","author":"Amanzio","year":"2020","journal-title":"Front Psychol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100253_bib0031","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17512433.2021.1900728","article-title":"How do nocebo effects in placebo groups of randomized controlled trials provide a possible explicative framework for the COVID-19 pandemic?","volume":"14","author":"Amanzio","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100253_bib0032","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/acr.20160","article-title":"Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines","volume":"62","author":"Nestoriuc","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100253_bib0033","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":"Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100253_bib0034","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40259-017-0233-6","article-title":"Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis","volume":"31","author":"Park","year":"2017","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100253_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/annrheumdis-2011-200170","article-title":"Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE","volume":"71","author":"Tak","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100253_bib0036","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-3999(03)00629-9","article-title":"Subjective health complaints, sensitization, and sustained cognitive activation (stress)","volume":"56","author":"Eriksen","year":"2004","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100253_bib0037","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s13063-018-3042-4","article-title":"Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials","volume":"19","author":"Howick","year":"2018","journal-title":"Trials"},{"issue":"10225","key":"10.1016\/j.lanepe.2021.100253_bib0038","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(20)30461-X","article-title":"How to fight an infodemic","volume":"395","author":"Zarocostas","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100253_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/omi.2020.0208","article-title":"Rethinking Clinical Trials and Personalized Medicine with Placebogenomics and Placebo Dose","volume":"25","author":"\u00d6zdemir","year":"2021","journal-title":"OMICS"},{"issue":"10088","key":"10.1016\/j.lanepe.2021.100253_bib0040","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","volume":"389","author":"Gupta","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lanepe.2021.100253_bib0041","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2019.00167","article-title":"Can Positive Framing Reduce Nocebo Side Effects? Current Evidence and Recommendation for Future Research","volume":"10","author":"Barnes","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.lanepe.2021.100253_bib0042","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12879-015-0765-7","article-title":"An effective strategy for influenza vaccination of healthcare workers in Australia: experience at a large health service without a mandatory policy","volume":"15","author":"Heinrich-Morrison","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100253_bib0043","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0895-4356(96)00177-1","article-title":"Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization [published correction appears in J Clin Epidemiol 1997 Jun;50(6):747-8]","volume":"49","author":"O'Connor","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:46:50Z","timestamp":1763009210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776221002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"alternative-id":["S2666776221002398"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100253","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100273","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100253"}}